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Flux studies using either radioisotopes or ion-selective electrodes are a convenient method to assay the function of the cystic fibrosis
transmembrane conductance regulator (CFTR) Cl channel. Here, we described three different protocols to study the properties, regulation
and pharmacology of the CFTR Cl channel in populations of cells and artificial vesicles. These techniques are widely used to evaluate the
function of wild-type and mutant CFTR prior to detailed analyses using the patch-clamp technique. Moreover, they have proved especially
valuable in the search for new drugs to treat cystic fibrosis.
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1. Introduction A second method is based on the use of an iodide-selectiveRadiotracer flux methods define a range of techniques
that allow the determination of ion channel activity in either
native cell membranes or artificial vesicles (proteolipo-
somes). Almost all ion channels can be studied using the
appropriate radiotracer: calcium channels with 45Ca, potas-
sium channels with either 86Rb or 42K, sodium channels
with 22Na, and chloride channels with either 36Cl or 125I.
The iodide efflux technique is a convenient method to assay
the function of cystic fibrosis transmembrane conductance
regulator (CFTR) Cl channels in a population of cells. This
method provides functional data by measuring ionic flux,
achieves higher throughput than the patch-clamp technique
and is less prone to artifacts than fluorescence-based assays.1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.05.025
Abbreviations: cpm, counts per minute; IBMX, isobutylmethylxan-
thine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS,
phosphatidylserine.
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E-mail address: frederic.becq@univ-poitiers.fr (C. Norez).electrode to detect iodide (I) in the solution bathing cells. In
this way, the use of radioisotopes is avoided. A third approach
is the study of flux using vesicles. This consists of a
concentrative tracer uptake assay, using 36Cl, to characterize
the Cl conductance of reconstituted CFTR channels. Fur-
thermore, it permits a macroscopic view of the number of
active CFTR channels and their regulation. Here, we provid-
ed an overview of these methods.2. Standard protocol using radioisotopes
Cells expressing CFTR (e.g., native, recombinant, even
oocytes injected with cRNA) are cultured under standard
conditions in multiwell plates. The number of wells per
plate depends on the equipment used, i.e., 6, 12, or 24 wells
using a manual protocol or 24, 48, or 96 wells using a
robotic system. The culture medium used to maintain cells
must be rinsed first and replaced by a standard solution called
‘‘the efflux buffer’’ that contains, for example (in mM): 150ed by Elsevier B.V. All rights reserved.
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HEPES, pH 7.4, and glucose (1 mg/ml). For 36Cl assays, all
Cl salts must be replaced by nitrate salts. The flux assay can
be performed at 37 jC simply by using a thermoregulated
bath. Cells washed by the efflux buffer at 37 jC, are then
loaded with 125I or 36Cl (1 AM as Na125I or Na36Cl, NEN,
Boston, MA) for several minutes at 37 jC. The incubation
time depends on the diffusion of the radiotracer into the cell.
For example, with CHO, Cos-7, HeLa, or NIH-3T3 cells, 30
min is sufficient for radiotracer uptake by cells. However, for
epithelial cells such as Calu-3, CF15, IB-3, T-84, the loading
time must be increased to 60–120 min to achieve adequate
loading of radiotracer. Preliminary experiments are recom-
mended to determine the appropriate loading time. After the
loading period, the extracellular radioactivity must be re-
moved by washing the cells vigorously using a large volume
of tracer-free efflux buffer. This is a very important step
because if extracellular radioactivity is too high this will mask
any efflux of radioactivity from the cells. Typically, for a
volume of 500 Al/well, 10 to 12 ml of washing solution is
used. Cells are washed as quickly as possible. The last aliquot
(500 Al) of efflux buffer used to wash the cells corresponds to
the first control data point. The loss of intracellular 125I or
36Cl is determined by replacing the efflux buffer with fresh
buffer every 1 min for up to 10 min and counting the
radioactivity in each sample. The first four aliquots are used
to establish a stable baseline in efflux buffer alone. Amedium
containing the appropriate drug [e.g., forskolin, isobutylme-
thylxanthine (IBMX), etc.] is used for the remaining aliquots.
Residual radioactivity, accumulated inside cells after the 10-
min period, is extracted with 0.1 N NaOH and determined
using a gamma counter for 125I or beta counter with scintil-
lation fluid for 36Cl. Detailed procedures are published
elsewhere [1–5].3. Mathematical analyses of CFTR-dependent
radiotracer efflux
An efflux from one compartment (the cell) into another
(the extracellular medium) can be viewed as an exponential
decay of the radioisotope (125I or 36Cl). The total content
of radioisotope in the sample decreases with time because
there is less and less radioisotope inside the cell. Then, the
fraction of initial intracellular radioisotope lost during each
time point can be determined and the time-dependent rate of
efflux (k) calculated from:
k ¼ lnðXt1=Xt2Þ=ðt1  t2Þ
where Xt is the intracellular radioisotope at time t, and t1 and
t2 are successive time points [1]. The format of the results for
an efflux experiment is counts per minute (cpm). The cpm
data points must be further transformed to calculate either the
rate constant or the percentage of efflux. Curves are con-
structed by plotting the rate of efflux vs. time. All compar-isons are based on maximal values for the time-dependent
rates excluding the points used to establish the baseline [3,4].
A cAMP-agonist (e.g., forskolin) opens CFTR channels
allowing a flow of Cl (and I) to pass through the pore
of the channel. This results in a rapid increase of k within the
first 2 min. The rate constant becomes maximal (peak value)
after 2 or 3 min and then decreases and return to its basal
value [3,4]. Alternatively, I efflux data may be presented as
the percentage of cellular I lost as a function of time [2]. In
the absence of agonist, the percentage slowly increases
because of the passive efflux of 125I. With an agonist, a
saturating curve is obtained, meaning that within the first 2 or
3 min, more than 50% and up to 90% of the initial cellular
content of 125I is lost.4. Standard protocol using ion-selective electrode
The release of I into the solution bathing cells can also
be detected using an I-selective electrode connected to a pH
meter. The protocol is similar to that described for radio-
isotopes, with the exception that all Cl in the efflux buffer is
substituted by NO3
, because Cl interferes with the opera-
tion of the electrode. For further information, see Ref. [6].5. Standard protocol using vesicles
In this assay, a chemical driving force favouring Cl efflux
is generated by suspending proteoliposomes containing pu-
rified CFTR (see Ref. [7]) loaded with KCl (140 mM), into a
Cl-free solution (containing K glutamate). Cl efflux sub-
sequently leads to the development of an intraliposomal
potential difference (positive inside), which drives the cumu-
lative uptake of 36Cl from the bath. Overall, if the proteo-
liposomes contain active Cl channels, cold Cl inside the
liposome is exchanged for 36Cl in response to the produc-
tion of an electrical driving force. This electrogenic flux assay
requires the proper reconstitution of CFTR molecules into
proteoliposomes, a process that is essential for obtaining
functionally active and correctly folded proteins. Thus, the
choice of lipid composition is of great importance for the
reconstitution procedure, since these phospholipids must give
rise to well-sealed proteoliposomes. The following combina-
tion of phospholipids has been shown to be particularly
effective for studying purified and reconstituted CFTR chan-
nels: phosphatidylethanolamine (PE), phosphatidylserine
(PS), phosphatidylcholine (PC), and ergosterol. Detailed
procedures are published elsewhere [7,8,9].6. Pharmacology of CFTR and application to drug
discovery
Flux studies are easy to set up without the expenses
associated with other techniques and therefore are preferred
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regulation of CFTR and the discovery of new drugs to treat
cystic fibrosis. Although these methods are valuable tools,
several properties of ion channels cannot be studied using
efflux assays. These include open probability, number of
active channels, voltage dependence and anion selectivity.
Finally, the I efflux assay can be used for high-through-
put screening (HTS) of libraries of chemicals to identify new
CFTR modulators. The I efflux assay is ideal for this
purpose. It allows the rapid determination of channel activity
for a large number of compounds, provides a large number of
standardized experiments and permits the construction of
structure–activity relationships (SARs). In addition, the
technique gives a sensitive readout when measuring com-
pound potency, potentiation and competition. Any lead
compound is further studied using electrophysiological meth-
ods for in-depth characterization of the pharmacological
effects.Acknowledgements
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